2-aminothiazole has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
2-aminothiazole: RN given refers to parent cpd; structure
1,3-thiazol-2-amine : A primary amino compound that is 1,3-thiazole substituted by an amino group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leone, S | 1 |
| Mutti, C | 1 |
| Kazantsev, A | 1 |
| Sturlese, M | 1 |
| Moro, S | 1 |
| Cattaneo, E | 1 |
| Rigamonti, D | 1 |
| Contini, A | 1 |
1 other study available for 2-aminothiazole and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington's disease.
Topics: Gene Expression Regulation; Gene Library; Gene Silencing; Huntington Disease; Models, Molecular; Mol | 2008 |